Format

Send to

Choose Destination
Oncotarget. 2018 Nov 6;9(87):35719-35720. doi: 10.18632/oncotarget.26279. eCollection 2018 Nov 6.

A triple drug combination as a novel anti-glioma therapy?

Author information

1
Markus D. Siegelin: Department of Pathology & Cell Biology, Columbia University Medical Center, New York, New York, U.S.A.

KEYWORDS:

OTX015; glioblastoma; panobinostat; sorafenib; triple drug combination therapy

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center